1. Letter to the editor: disaggregating Asian prostate cancer cohorts can help us improve care for all prostate cancer patients;Nguyen DD,2023
2. Impact of Asian race on prognosis in de novo metastatic prostate cancer;Ni X,2023
3. Charting a path towards asian american cancer health equity: a way forward;Chen MS,2022
4. Epidemiology and genomics of prostate cancer in Asian men;Zhu Y,2021
5. Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial;Saad F